Understand the source comparison
LL-37 Immune Support Protocol: Timing Comparison
Single morning dose (6:00–8:00 AM, fasted) 45–90 minutes post-injection High. Aligns with circadian NK cell and macrophage activity peak Low. Gastric pH elevated from overnight fast, no food competition Low. Neutrophil elastase activity at daily nadir Optimal
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Single morning dose (6:00–8:00 AM, fasted)
- 45–90 minutes post-injection
- High. Aligns with circadian NK cell and macrophage activity peak
- Low. Gastric pH elevated from overnight fast, no food competition
- Low. Neutrophil elastase activity at daily nadir
- Optimal for most individuals. Highest functional immune response despite single daily peak.
- Split dose (morning + evening)
- Two peaks: 7:00–9:00 AM and 11:00 PM–1:00 AM
- Moderate. Covers two immune surveillance windows but neither at full circadian peak
- Moderate. Evening dose may coincide with dinner digestion
- Moderate. Afternoon protease activity affects second dose timing
- Maintains stable plasma levels but sacrifices circadian alignment. Best for individuals with demonstrated need for sustained antimicrobial coverage.
- Single evening dose (10:00 PM–12:00 AM, fasted)
- 11:00 PM–1:30 AM
- Moderate. Aligns with nocturnal immune repair but misses daytime pathogen exposure window
- Low. If taken 3+ hours post-dinner
- Low. Protease activity reduced during sleep
- Useful for shift workers or individuals with reversed circadian rhythms. Suboptimal for standard sleep schedules.
- Random timing (non-fasted, inconsistent schedule)
- Unpredictable. Delayed or blunted by food, beverages, co-administered supplements
- None. No alignment with circadian immune rhythms
- High. Gastric pH disruption from food, competitive absorption from other compounds
- High. Overlaps with peak protease windows 40–60% of the time
- Produces inconsistent bioavailability and immune response. Wastes the peptide's therapeutic potential through poor timing alone.